Perjeta, which is pertuzumab, is a significant advancement in addressing HER2-positive certain types of cancer. This drug works by targeting a particular pathway on helps cancer cells proliferate. Differing from some alternative HER2-targeted therapies, pertuzumab doesn’t directly block the HER2 rec